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The dysbiotic feature of the microbiota in inﬂammatory
bowel disease patients (eg, decreased diversity) was
reproduced in humanized gnotobiotic mice. The microbiota
isolated from patients with Crohn’s disease and ulcerative
colitis was shown to have altered bacterial function in hu-
manized gnotobiotic mice as shown by bacterial functional
gene analysis and luminal metabolome analysis. Host gene
expression induced in humanized gnotobiotic mice owing to
colonization by the microbiota isolated from patients with
Crohn’s disease resembled the core gene expression pat-
terns observed in the intestinal mucosa of Crohn’s disease
patients; the microbiota also promoted the development of
colitis when used to colonize inﬂammatory bowel disease–
prone interleukin 10–deﬁcient mice.
BACKGROUND & AIMS: Gut dysbiosis is closely involved in the
pathogenesis of inﬂammatory bowel disease (IBD). However, it
remains unclear whether IBD-associated gut dysbiosis con-
tributes to disease pathogenesis or is merely secondary to in-
testinal inﬂammation. We established a humanized gnotobiotic
(hGB) mouse system to assess the functional role of gut dys-
biosis associated with 2 types of IBD: Crohn’s disease (CD) and
ulcerative colitis (UC).
METHODS: Germ-free mice were colonized by the gut micro-
biota isolated from patients with CD and UC, and healthy con-
trols. Microbiome analysis, bacterial functional gene analysis,
luminal metabolome analysis, and host gene expression anal-
ysis were performed in hGB mice. Moreover, the colitogenic
capacity of IBD-associated microbiota was evaluated by colo-
nizing germ-free colitis-prone interleukin 10–deﬁcient mice
with dysbiotic patients’ microbiota.
RESULTS: Although the microbial composition seen in donor
patients’ microbiota was not completely reproduced in hGB
mice, some dysbiotic features of the CD and UC microbiota (eg,
decreased diversity, alteration of bacterial metabolic functions)
were recapitulated in hGB mice, suggesting that microbial
community alterations, characteristic for IBD, can be repro-
duced in hGB mice. In addition, colonization by the IBD-
associated microbiota induced a proinﬂammatory gene
expression proﬁle in the gut that resembles the immunologicsignatures found in CD patients. Furthermore, CD microbiota
triggered more severe colitis than healthy control microbiota
when colonized in germ-free interleukin 10–deﬁcient mice.
CONCLUSIONS: Dysbiosis potentially contributes to the path-
ogenesis of IBD by augmenting host proinﬂammatory immune
responses. Transcript proﬁling: GSE73882. (Cell Mol Gastro-
enterol Hepatol 2016;2:468–481; http://dx.doi.org/10.1016/
j.jcmgh.2016.02.003)
Keywords: Dysbiosis; Microbiota; Crohn’s Disease; Ulcerative
Colitis.
he resident gut microbiota is essential for numerousTvital host physiological processes, including diges-
tion of dietary factors, development of the gut immune
system, and colonization resistance against incoming path-
ogens.1 Not surprisingly, a breakdown of the homeostatic
relationship between the host and the microbiota can lead to
the development of various intestinal and extraintestinal
disorders, including inﬂammatory bowel disease (IBD).1 IBD
comprises 2 major disorders, Crohn’s disease (CD) and
ulcerative colitis (UC), characterized by chronic inﬂamma-
tion of the gastrointestinal tract.2,3 Although the precise
etiology of IBD has not yet been deﬁned, it is widely accepted
that the gut microbiota is central to the initiation and
persistence of disease. Indeed, intestinal inﬂammation only
develops in the presence of a conventional microbiota in
most experimental models of IBD, whereas animals housed
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inﬂammation.1,4–6 In IBD patients, alterations in the gut
microbiota have been identiﬁed repeatedly and termed
dysbiosis.7 However, it remains unclear whether dysbiosis
contributes to the pathogenesis of IBD or is merely a sec-
ondary factor that develops as a result of gut inﬂammation.
In support of a pathogenic role of gut dysbiosis in IBD
patients, it has been reported that certain pathobionts, such
as adherent-invasive Escherichia coli strains, accumulate in
patients with CD as a result of gut dysbiosis. These patho-
bionts are capable of facilitating intestinal inﬂammation in
experimental models.8–11 Likewise, a potential mechanism is
suggested by the observation that perturbations in the
metabolic function of the microbiota, caused by dysbiosis,
can inﬂuence the production of immune-regulatory bacterial
byproducts, such as short-chain fatty acids (SCFAs), thereby
compromising mucosal defense.12 Furthermore, a recent
report showed that gut dysbiosis and an altered host gene
expression proﬁle were observed in the ileum of histologi-
cally normal tissues in treatment-naive, newly diagnosed
patients with CD colitis.13 Thus, it is conceivable that
dysbiosis is not simply a result of inﬂammation. Rather,
dysbiotic microbiota is functionally defective and contributes
to inﬂammation. However, as of now, a detailed mechanism
connecting IBD-associated dysbiosis and the resultant
detrimental host immune responses has not been elucidated.
Alternatively, it has been reported that intestinal inﬂam-
mation alters the community structure of the microbiota.14–16
The mucosal inﬂammatory milieu selectively fuels the growth
of facultative anaerobes, including Proteobacteria, at the
expense of obligate anaerobes, including Firmicutes and
Bacteroidetes. These conditions give rise to blooms of facul-
tative anaerobes, such as E coli.14,15 The overgrowth of certain
bacteria resulting from intestinal inﬂammation skews the
balance of the whole microbial community, leading to lower
diversity. Consistently, low diversity and richness of the gut
microbial community along with an increased abundance of
Enterobacteriaceae, including E coli, and decreased abun-
dance of the phylum Firmicutes, are observed in patients with
IBD.11,12,17 Thus, gut dysbiosis in IBD may be a secondary
manifestation of intestinal inﬂammation
The gnotobiotic (GB) mouse model, in which GF mice are
colonized with selected known populations of bacteria, is a
powerful system used to characterize the functions of bac-
terial populations in vivo.18 GB mice also can be used to
evaluate the function of humanmicrobiota in mice.19,20 Many
studies have shown that it is possible to recapitulate the
metabolic features of human microbiota in humanized GB
(hGB) mice.19,20 For instance, hGB mice colonized with the
microbiota isolated from obese patients, as compared with
lean controls, tend to becomemore obesewhen they are fed a
high-fat diet, indicating that functional features of the dis-
ease-associated microbiota can be recapitulated successfully
in mice.21 In the present study, we established this model to
functionally characterize the dysbiotic microbiota from IBD
patients. By using hGB mice colonized with the microbiota
isolated from patients with CD and UC, we showed that
dysbiosis, present in the donor microbiota, can be recapitu-
lated, at least to some extent, in mice. Certain dysbioticfeatures (eg, lower community diversity) associated with
donor patients’ stool samples were reproduced in recipient
mice, and the resulting microbial metabolic proﬁles were
different. Likewise, colonization by the IBD-associated dys-
biotic microbiota inﬂuenced gene expression proﬁles in the
colon, showing that the microbiota in CD and UC has a
distinct functional impact on host immunity. Strikingly, we
also found that the microbiota from CD patients induced
more severe intestinal inﬂammation when colonized in GF
interleukin (IL)10-deﬁcient mice, a mouse model for CD.
Materials and Methods
Donor Stool Sample Preparation
Stool samples were obtained from patients with CD and
UC and healthy control subjects according to the University
of Michigan Institutional Review Board–approved protocol
(IBD databank, HUM00041845). Written informed consent
forms were obtained before sample collection. Donor
patients and control subjects were not treated with any
antibiotics for at least 3 months before sample collection,
and had no history of intestinal bacterial infections such as
Clostridium difﬁcile, or other infections such as hepatitis B
virus, hepatitis C virus, or human immunodeﬁciency virus.
Patients had been histologically and endoscopically diag-
nosed with CD or UC. Patients with ostomy were excluded.
Collected stool samples were stored at -80C until use.
Before inoculation, stool samples were diluted 1:10 with
pre-reduced phosphate-buffered saline under anaerobic
conditions. Diluted stool samples then were passed through
a 100-mm cell strainer and orally inoculated (100 mL per
mouse) into GF C57BL/6 mice.
Mice
GF C57BL/6 mice were housed in the Germ-Free Animal
Facility at the University of Michigan. GF mice were main-
tained in ﬂexible ﬁlm isolators and were checked weekly for
GF status by aerobic and anaerobic culture. The absence of
the microbiota was veriﬁed by microscopic analysis of
stained cecal contents that detects any unculturable
contamination. Eight- to 16-week-old female and male mice
were used for experiments. For the generation of hGB mice,
stool samples, which were obtained from control and IBD
donors (as described earlier), were orally inoculated into 2–5
recipient GF C57BL/6 mice per donor. The hGB mice were
housed in positive-pressure individual ventilated cages
(IVCs) (ISOcage P; Techniplast, West Chester, PA) per con-
dition to prevent cross-contamination among the different
groups and maintain gnotobiotic conditions.22,23 All mice
were fed a sterilized rodent breeder diet 5013 (LabDiet, St.
Louis, MO). All animals were handled in accordance with the
protocols approved by the Institutional Animal Care and Use
Committee at the University of Michigan.
Bacterial DNA Isolation
Stool samples were obtained from individual donor or
hGB mice (stool samples from multiple mice colonized with
the same microbiota and housed in the same IVC were
pooled). Genomic DNA was extracted by using a modiﬁed
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(Valencia, CA). These modiﬁcations included the following:
(1) adding a bead-beating step using UltraClean fecal DNA
bead tubes (Mo Bio Laboratories, Inc, West Carlsbad, CA)
that were shaken using a Mini-Beadbeater-16 (BioSpec
Products, Inc, Bartlesville, OK) for 1.5 minutes; (2)
increasing the amount of buffer ATL used in the initial steps
of the protocol (from 180 to 360 mL); (3) increasing the
volume of proteinase K used (from 20 to 40 mL); and (4)
decreasing the amount of buffer AE used to elute the DNA at
the end of the protocol (from 200 to 85 mL).Bacterial 16S rRNA Sequencing
Samples were submitted to the University of Michigan
Medical School Host Microbiome Initiative and processed
using the MiSeq Illumina sequencing platform. 16S ribo-
somal RNA (rRNA) gene libraries were constructed using
primers speciﬁc to the V4 region.Operational Taxonomic Unit Assignment and
Diversity Measurements
Sequences were curated using the community-supported
software program mothur (v.1.33)24 and by following the
steps outlined in the MiSeq SOP (http://www.mothur.org/
wiki/MiSeq_SOP).25 Sequences were assigned to opera-
tional taxonomic units (OTUs) using a cut-off value of 0.03
and classiﬁed against the Ribosomal Database Project 16S
rRNA gene training set (version 9) using a naive Bayesian
approach with an 80% conﬁdence threshold. Curated OTU
sequence data were converted to relative abundance ± SEM.
Within-community diversity (a-diversity) was calculated
using the Shannon diversity index (H’) and OTU richness.
Between-community diversity (b-diversity) was determined
using the Yue and Clayton dissimilarity distance metric.
Nonmetric multidimensional scaling was used to ordinate
the b-diversity data. An analysis of molecular variation was
used to test for signiﬁcant differences in the community
structure using 10,000 permutations. The functional aspect
of the bacterial community was investigated using the OTU-
based bacterial signaling analysis phylogenetic investigation
of communities by reconstruction of unobserved states.26
To test which functional pathways were differentially
abundant, biologically consistent, and had the greatest effect
size, we used linear discriminant analysis effect size.27Capillary Electrophoresis Time-of-Flight Mass
Spectrometry–Based Metabolome Analysis
Capillary electrophoresis time-of-ﬂight mass spectrom-
etry (CE-TOFMS)–based metabolome analysis was
conducted as described previously with some modiﬁca-
tions.28 In brief, fecal samples were lyophilized by using a
VD-800R lyophilizer (TAITEC, Saitama, Japan) for 24 hours.
Freeze-dried feces were disrupted with 3.0-mm Zirconia
Beads (Biomedical Science, Tokyo, Japan) by vigorous
shaking (1500 rpm for 10 min) using Shake Master
(Biomedical Science). Fecal metabolites were extracted
by the methanol:chloroform:water extraction protocol.CE-TOFMS experiments were performed using the Agilent
CE System, the Agilent G3250AA LC/MSD TOF System, the
Agilent 1100 Series Binary HPLC Pump, the G1603A Agilent
CE-MS adapter, and the G1607A Agilent CE-ESI-MS
SprayerKit (all Agilent Technologies, Santa Clara, CA).
Host Gene Expression Analysis
Colonic tissues were harvested from hGB mice 14 days
after microbiota colonization. RNA was extracted using the
ENZA Total RNA Kit (Omega Biotek, Norcross, GA) according
to the manufacturer’s protocol. RNA integrity number was
measured using a bioanalyzer instrument (Agilent Technol-
ogies) and ranged from 9.2 to 9.6, with 28S/18S ratios be-
tween 1.8 and 1.9. Target-labeled complementary RNA was
hybridized to a GeneChip Mouse Gene ST 2.1 array (Affy-
metrix, Santa Clara, CA). Data were normalized with the
robust multi-array average procedure using the affy package
of Bioconductor implemented in the R statistical language.
Induction of Colitis in IL10-Deﬁcient Mice
Fecal samples were obtained from HC and CD hGB re-
pository mice and were used to prepare the donor micro-
biota samples. Fecal samples isolated from hGB mice (>14
days after reconstitution) were inoculated into GF Il10-/-
mice. GB mice colonized with microbiota from a single donor
were housed in an IVC to prevent cross-contamination
among groups. Three weeks after fecal transplantation us-
ing the microbiota from hGB mice donors, the reconstituted
Il10-/--hGB mice were killed, and ceca and colons were
collected. Colonic length andweight weremeasured and then
ﬁxed with 4% paraformaldehyde. Fixed tissues were pro-
cessed for H&E staining. Histologic assessment was per-
formed by a pathologist in a blinded fashion at the Unit for
Laboratory Animal Medicine in vivo Animal Core. For his-
tology scoring, a 4-point scale was used to denote the
severity of inﬂammation (0, none; 1, minimal multifocal
inﬂammation [few foci]; 2, moderatemultifocal inﬂammation
[numerous foci]; 3, severe multifocal coalescing inﬂamma-
tion; and 4, same as a score of 3 with abscesses or extensive
mural involvement), the edema scores (0, none; 1, mild focal
or multifocal edema, minimal submucosal expansion (<2);
2, moderate focal or multifocal edema, moderate submucosal
expansion (2–3); 3, severe multifocal to coalescing
inﬂammation; and 4, same as a score of 3 with diffuse sub-
mucosal expansion), and the epithelial score (0, none; 1, mild,
multifocal, superﬁcial damage; 2, moderate, multifocal, su-
perﬁcial damage; 3, evere, multifocal to coalescing mucosal
damage ± pseudomembrane ± ulcer; 4, same as a score of 3
with signiﬁcant pseudomembrane or ulcer formation). Each
variable then was summed to obtain the overall score.
Quantiﬁcation of Flagellin
Flagellin levels in feces were measured by using HEK-
Blue mTLR5 cells (Invivogen, San Diego, CA) according to a
previously reported method.29 Fecal samples were obtained
from hGBmice and homogenized for 10 seconds using a bead
beater (Biospec Products, Bartlesville, OK). Homogenized
fecal samples were centrifuged at 8000 g for 2minutes and
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were suspended in the HEK-Blue detection medium and
stimulated with serially diluted homogenate fecal superna-
tants. Stimulated cells were incubated for 6 hours at 37C
and reporter activity (alkaline phosphatase activity) was
measured at 640 nm. Puriﬁed ﬂagellin (from Salmonella
typhimurium; Invitrogen) was used as a standard.
Statistical Analyses
Statistical analyses were performed using GraphPad
Prism software version 5.0 (GraphPad Software, Inc, San
Diego, CA). Differences between 2 groups were evaluated
using the Student t test (parametric) or the Mann–Whitney
U test (nonparametric). For the comparison of more than 3
groups, statistical analysis was performed using 1-way
analysis of variance (parametric) or the Kruskal–Wallis
test (nonparametric), followed by the Bonferroni correction
for parametric samples, or the Dunn test for nonparametric
samples as a post hoc test. P values less than .05 were
considered signiﬁcant.
Results
Gut Dysbiosis Associated With IBD Is
Reproduced in hGB Mice
To directly test the function of IBD-associated dysbiosis,
we ﬁrst attempted to establish an hGB mouse model by
inoculating GF mice with IBD-associated dysbiotic micro-
biota. Stool samples were obtained from 5 healthy controls
(HC-01–HC-05), 5 CD patients (CD-01–CD-05), and 4 UC
patients (UC-01–UC-04), and they were used to orally inoc-
ulate GF C57BL/6 mice. Mice were kept under GF conditions
for 2 weeks to allow for complete reconstitution with the
human microbiota.30 To analyze the microbial composition
before and after humanization of the GF mice, donor stool
samples and stool samples from recipient hGB mice were
collected and analyzed by 16S rRNA sequencing (Figure 1).
Compared with HC donor microbiota, the UC donors, in
particular, showed a lower abundance of Firmicutes, a
greater abundance of Proteobacteria, and more variability in
the abundances of predominant bacterial taxa among indi-
vidual samples, consistent with data from larger cohorts
(Figure 2A and Supplementary Table 1). Interestingly,
apparent changes in the CD donor microbiota were less
obvious (Figure 2A and Supplementary Table 1). As shown in
Figure 2B, the microbiota from HC, CD, and UC stool donors
tends to fall into different clusters, which is shown in the
nonmetric multidimensional scaling plot. After reconstitu-
tion in GF mice, these 3 groups still showed different com-
munity structures (Figure 2B). Because there was substantial
variability within each group, the between-group differences
were not statistically signiﬁcant (Figure 2B). The a-diversity
of the CD and UC donor communities was signiﬁcantly lower
compared with the HC donors as measured by the Shannon
diversity index and OTU richness (Figure 2C). These dys-
biotic features were noted in the recipient mice as well, and
a-diversity (Shannon diversity index) was signiﬁcantly lower
in hGBmice colonizedwith themicrobiota from patients with
CD and UC (Figure 2C). Even though a similar decrease inmicrobial richness could be observed in UC and CD hGB mice
after reconstitution, the difference was not statistically sig-
niﬁcant (Figure 2C). These results suggested that hGB mice
colonized with the microbiota from IBD patients show dys-
biosis, at least to some extent, as observed in the original
stool samples.Microbial Metabolic Pathways Are Perturbed
in IBD
To assess for the presence of a potential functional
defect in the IBD-associated dysbiotic microbiota recapitu-
lated in GB mice, we next predicted the functions of the
microbial communities by using the phylogenetic investi-
gation of communities by reconstitution of unobserved
states algorithm (Phylogenetic Investigation of Communities
by Reconstitution of Unobserved States).26 The predicted
functional pathways signiﬁcantly affected by dysbiosis in
patients with CD or UC were identiﬁed in hGB recipient mice
by using the linear discriminant analysis effect size
approach.27 As shown in Figure 3, genes related to ﬂagellar
assembly and bacterial motility proteins were signiﬁcantly
over-represented and genes involved in certain metabolic
pathways, such as carbohydrate and bile acid metabolism,
were under-represented in CD hGB mice compared with HC
hGB mice. In UC hGB mice, glycolysis/gluconeogenesis-
related genes were over-represented compared with HC
hGB mice, whereas genes associated with bacterial homeo-
stasis (eg, DNA replication, peptidoglycan synthesis) and
certain metabolic pathways (eg, propanoate metabolism)
were signiﬁcantly reduced (Figure 3). There were also sig-
niﬁcant differences in predicted metabolic function between
CD hGB and UC hGB mice. Certain metabolic genes were
over-represented in CD but not in UC (Figure 3). These re-
sults suggested that dysbiosis in IBD is predicted to
compromise the metabolic function of the microbiota.
Furthermore, CD-associated and UC-associated dysbiosis
result in distinct functional alterations of the microbiota. We
also analyzed the functional proﬁle of the microbial com-
munities present in human donor stool samples based on
16S rRNA sequence results (Supplementary Figure 1). There
also were signiﬁcant differences in predicted metabolic
function among HC, CD, and UC donor samples
(Supplementary Figure 1). However, the predicted func-
tionality differences observed in the microbiota of HC, CD,
and UC donor samples did not fully correlate with the dif-
ferences observed upon reconstitution of hGB mice
(Figure 3 and Supplementary Figure 1).
To conﬁrm the result of the predictive functional gene
analysis, we next analyzed the metabolome of hGB mice
colonized with IBD and control microbiota using CE-TOFMS.
As shown in Figure 4A and Supplementary Table 2, hGB
mice colonized with IBD microbiota showed distinct meta-
bolic proﬁles compared with hGB mice reconstituted with
HC microbiota. Principal component analysis showed that
metabolome of humanized hGB mice is distinct from that of
GF controls, conﬁrming that colonization of human micro-
biota alters the luminal metabolome (Figure 4B). The
metabolome in CD hGB seemed to cluster differently from
Figure 1. Analysis of
functional dysbiosis in
IBD. Stool samples were
obtained from healthy
control subjects and
patients with IBD (Crohn’s
disease and ulcerative
colitis). Intestinal bacteria
then were inoculated into
GF WT mice (hGB mice).
After 2 weeks of recon-
stitution, gut microbiome
(16S rRNA sequencing),
luminal metabolome (CE-
TOF/MS), and host gene
expression proﬁle (DNA
microarray) in hGB mice
were analyzed. For eval-
uation of the colitogenic
capacity of the micro-
biota, established hGB
mice were used as stool
donors. Stool samples
obtained from HC- or
IBD-hGB mice were
transplanted into either
GF WT B6 mice or GF
Il10-/-mice. After 3 weeks
of reconstitution, intestinal
inﬂammation was exam-
ined. mRNA, messenger
RNA.
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discriminate analysis of the CE-TOFMS–based metabolome
data indicated that the amount of luminal SCFAs, such as
propionate and butyrate, succinate, 5-aminovalerate, and
taurine, was higher in hGB mice than in GF mice, indicating
that generation of these metabolites are microbiota-
dependent (Figure 4C and D). CD hGB mice showed a
trend toward an increase in SCFAs compared with HC hGB
mice, whereas the amount of SCFAs in UC hGB mice was
similar to HC hGB (Figure 4D). The amount of certain me-
tabolites, including threonine and urea, was lower after
bacterial colonization, suggesting that these metabolites are
consumed and/or degraded by the microbiota (Figure 4C
and D). These results show that the metabolic functions of
the HC and IBD microbiota of hGB mice are distinct, and this
suggests a possible mechanism by which IBD dysbiosis may
inﬂuence disease susceptibility in the host.Dysbiotic Microbiota in IBD Inﬂuences
Differentially Regulated Mucosal Gene
Expression Patterns
To explore the functional impact of dysbiotic microbiota
in IBD patients on host immune responses, we next
analyzed gene expression proﬁles in the colonic mucosa of
hGB mice colonized with HC, CD, and UC microbiota.Colonization of HC microbiota induced expression of genes
associated with the epithelial response to microbes (eg,
Reg3b/3g, Cldn4, Duox2, Duoxa2, and Saa3) and
immunoglobulin-related genes in GF mice (Figure 5 and
Supplementary Table 3), suggesting that human microbiota
can promote mucosal maturation in mice. Colonization of CD
microbiota triggered stronger induction of certain epithelial
response genes (eg, Reg3b/3g, Mmp10) than HC microbiota
(Figure 5 and Supplementary Table 3). Likewise, coloniza-
tion of CD microbiota promoted expression of gene markers
for macrophages (major histocompatibility complex class II
genes, Fc receptor genes, Ccl2/Ccr2, Csf1r, Cd68, Lyz1),
dendritic cells (major histocompatibility complex class II
genes, FcR genes, Csf2rb, Flt3, Cd209a, Cd103), natural killer
(NK) cells (Gzma/b, Cd2, Cd96, Il2rb/g, Stat4), group3 innate
lymphoid cells (ILCs) (Ltb, Il2rg, Ccr6, Il7r, Ciita), T-helper
(Th)1 cells (Stat4, Ciita), and Th17 cells (Saa3, Irf4, Ccr6,
Il21r, Stat4) (Figure 5 and Supplementary Table 3).
Furthermore, many cytokines, chemokines, and their re-
ceptors (Il1b, il1r2, il1rl1, il18bp, Ccl2/5/8/22, Cxcl9/10/13,
Ccr2/5/6, Cxcr5) were up-regulated in hGB mice colonized
with CD microbiota (Figure 5 and Supplementary Table 3).
In contrast, certain genes related to solute carrier families
(Slc6a4/15a1/16a12/20a1/30a10/36a1/40a1/46a1) and
cytochrome P450 families (Cyp2c67/2c68/2d12/2d13/2f2/
27a1) were under-represented in CD hGB compared with
Figure 2. IBD-associated dysbiosis is recapitulated in humanized gnotobiotic mice. (A) Stool samples were obtained from
patients with CD, UC, and HCs, and then inoculated into GF mice. After 2 weeks of reconstitution, stool samples from hGB
mice were collected and bacterial 16S rRNA sequences were analyzed. Sample IDs of human donors correspond to those of
donor-derived hGB mice. (B) Microbial community structures were analyzed by using the Yue and Clayton dissimilarity dis-
tance metric (qYC) and are shown in a nonmetric multidimensional scaling plot. (C) Shannon index (a-diversity) and number of
OTUs (richness) for each group. Data are presented as means ± SD. *P < .05 by Student t test. ** P < .01.
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expression patterns in UC hGB mice were different from
those in CD hGB mice. Similar to CD, colonization with UC
microbiota also showed enhanced expression of certain
epithelial response genes, such as Saa3 and Duoxa2,
compared with HC microbiota (Figure 5 and Supplementary
Table 3). However, many genes found to be increased in CD
hGB mice were not up-regulated in UC hGB mice (Figure 5
and Supplementary Table 3). On the other hand, certain
genes, including genes related to lipid metabolism (Retn,
Abcg5/8, Adipoq, Apoc1, Apol7a) and some Th17-related
genes (Rorc, Retnla, Ccl20), were expressed at greater
levels in UC hGB than in CD hGB mice (Figure 5 and
Supplementary Table 3).Microbiota of CD Patients Confers Increased
Susceptibility to Experimental Colitis
Although colonization by the dysbiotic microbiota iso-
lated from CD patients elicited proinﬂammatory immuneresponses (eg, Th17, Th1, IL1b signaling) (Figure 5), none of
the microbiota samples triggered overt intestinal pathology,
with the exception of 1 patient (CD-03) (Figure 6A and B).
This suggests that in most cases CD-associated dysbiosis
does not immediately lead to pathogenesis under these
conditions. Notably, the microbiota derived from patient CD-
03 had the strongest inductive effect on proinﬂammatory
genes when used to colonize GF wild-type (WT) B6 mice
(Figure 5), indicating that this patient’s microbiota may
harbor pathogenic bacteria. We next assessed the colitogenic
capacity of CD dysbiotic microbiota in colitis-prone mice.
Upon colonization of GF IL10-/- mice, the HC microbiota did
not induce any overt signs of intestinal inﬂammation (ie,
colon thickening or intestinal pathology) (Figure 6C–E). In
contrast, the CD microbiota elicited the development of se-
vere colitis in GF IL10-/- mice. IL10-/- mice colonized with CD
microbiota showed signiﬁcantly increased colon weight and
overt intestinal pathology (Figure 6C–E). These results show
that the intestinal bacteria from CD patients can induce the
development of colitis in IBD-prone mice.
Figure 3. Microbial functional gene pathways in hGB mice. The abundance of Kyoto Encyclopedia of Genes and Genomes
metabolic gene pathways was analyzed by phylogenetic investigation of communities by reconstruction of unobserved states
based on 16S rRNA sequencing data in Figure 2. Signiﬁcantly altered pathway genes in 3 groups (HC-, CD-, and UC-hGB
mice) were identiﬁed by linear discriminant analysis effect size. The linear discriminant analysis (LDA) score is shown.
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New and provocative results have been published as of
late, supporting a potential pathogenic role for gut microbial
dysbiosis in the manifestation of IBD. Studies have reported
that changes in microbial composition and host gene
expression proﬁles of ileal tissue samples that do not show
histologic inﬂammation from newly diagnosed, treatment-
naive CD colitis patients, suggest a possible causal role for
IBD-associated dysbiosis.11,13 A potential mechanism for
dysbiosis-mediated host responses is suggested by recent
functional analyses of the microbiota in IBD, which showed
that certain metabolic functions of the microbiota are per-
turbed in IBD. For example, perturbed carbohydrate meta-
bolism suggests the compromised formation of SCFAs.
Because SCFAs play crucial roles in the development of
regulatory T cells and enhancement of the epithelial barrier
function,31–33 dysbiosis in IBD may compromise host regu-
latory immune responses. Also, amino acid metabolism is
signiﬁcantly altered in the dysbiotic microbiota associated
with IBD.12,34 In the clinical setting of IBD, there are sig-
niﬁcant inherent challenges in deciphering whether dys-
biosis contributes to disease pathogenesis or is merely a
secondary change associated with the disease process. Also,
it is not possible to exclude that these data could be
signiﬁcantly affected by environmental and host genetic
factors, including unappreciated inﬂammation. Therefore,
alternative approaches are required to unravel the true
impact of IBD-associated dysbiosis on host responses to rule
out any extrinsic factors and focus squarely on
host–microbial interaction. To this end, we have used the GB
mouse system to re-create IBD-associated dysbiosis in mice.As reported previously,19,20 we showed that the
microbiota harvested from human subjects, including IBD
patients, can stably colonize the gastrointestinal tract of
mice. However, the dysbiotic communities present in the
stool samples of IBD donors were not completely reca-
pitulated in hGB mice in our study. For example, although
an increased abundance of Proteobacteria was observed in
IBD donor stool samples, this phenomenon was not fully
reproduced in hGB mice. Because intestinal inﬂammation
is required for Proteobacteria to bloom in the gut, the lack
of complete reproducibility may be owing to different
levels of inﬂammation between IBD patients (donors) and
recipient mice. Likewise, the predicted functionality dif-
ferences in the donor group of microbiota samples did not
fully correlate with hGB mice because this analysis is
based on 16S rRNA sequencing results (Figure 3 and
Supplementary Figure 1). Given that IBD patients do
harbor genetic defects in the host response to microbes, it
is possible that these defects foster dysbiosis that is not
maintained in the murine gut. Likewise, other features
related to diet, environment, and host factors presumably
shape the microbiota after reconstitution in mice and
represent a limitation of this model. Nonetheless, certain
features of the dysbiotic microbiota, including decreased
bacterial diversity and richness, also were observed after
reconstitution in hGB mice. Ultimately, we did note lower
bacterial diversity, altered bacterial metabolite levels,
differential host response proﬁles, and an apparent dif-
ference in the potential to develop inﬂammation after
transfer of IBD-associated dysbiotic microbiota, showing
the potential utility of this model for assessing various
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Figure 5. Host gene
expression in the colonic
mucosa of hGB mice.
Host gene expression
induced by colonization of
human microbiota (HC, CD,
and UC). A heat map of
selected genes, which were
expressed differently in CD-
hGB or UC-hGB mice
compared with HC-hGB
mice, is shown. The color
range indicates the fold
expression of genes
compared with the average
expression in HC-hGB
mice.
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critical for the pathogenesis of IBD.
Beyond bacterial community analysis, focusing on the
functional changes of the microbiota caused by dysbiosis in
these experiments has yielded more thought-provokingFigure 4. (See previous page). Fecal metabolome proﬁles o
metabolic proﬁles. All concentrations of quantiﬁed metabolites
Euclidean distance. Gray areas in the heat map indicate that
component analysis of the metabolome data. The ellipse denot
Hotelling t test. (C) A loading scatter plot of the principal compon
propionate, butyrate, 5-aminovalerate, taurine, succinate, gluta
are presented as means ± SEM. *P < .05, ** P < .01. ND, not d
post hoc test. PC, principal component.results. A gene-based predictive analysis showed an in-
crease in genes involved in the pathogenic features of bac-
teria, including ﬂagellar assembly and bacterial motility
proteins, in CD hGB mice.35 Consistent with the gene-based
predictive analysis, the actual ﬂagellin load in feces tendedf GF and hGB mice. (A) A heat map showing the quantiﬁed
were transformed into Z-scores and clustered according to
respective metabolites were not detected. (B) The principal
es the 95% signiﬁcance limit of the model, as deﬁned by the
ent analysis. (D) The bar graphs showing the concentration of
mate, threonine, and urea in murine feces, respectively. Data
etected by 1-way analysis of variance, followed by the Tukey
Figure 6. CD-associated
microbiota promotes the
development of colitis in
IBD-prone mice. (A and
B) Stool samples were
isolated from HC-hGB
mice (HC-03, HC-04, and
HC-05) and CD-hGB mice
(CD-01, CD-02, CD-03,
CD-04, and CD-05), and
then inoculated into GF
WT B6 mice. After 3 weeks
of reconstitution, cecal
and colonic tissues were
harvested. (A) Histologic
score of colon. Each dot
indicates an individual
mouse. NS, not signiﬁcant
by Mann–Whitney U test.
(B) A representative histo-
logic image of WT B6-HC-
hGB and CD-hGB mice.
Scale bar: 200 mm. (C–E)
Stool samples were iso-
lated from HC-hGB mice
and CD-hGB mice and
then inoculated into GF
Il10-/- mice. After 3 weeks
of reconstitution, cecal
and colonic tissues were
harvested. (C) Colonic
weights. Each dot in-
dicates an individual
mouse. **P < .01 by
Mann–Whitney U test. (D)
Histologic score of colon.
Each dot indicates an in-
dividual mouse. **P < .01
by Mann–Whitney U test.
***P < .001. (E) A repre-
sentative histologic image
of colonic tissues isolated
from IL10-/--HC-hGB and
CD-hGBmice.Scalebar: 50
mm.
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(Supplementary Figure 2A). Notably, the higher production
of ﬂagellin by the CD microbiota became more obvious
when the microbiota was used to colonize GF Il10-/- mice
(Supplementary Figure 2B). This result suggests that the CD
microbiota contains bacteria that have the potential to ex-
press ﬂagellin, but ﬂagellin expression is not turned on
under physiological conditions. In certain microenviron-
ments, such as during intestinal inﬂammation and/or owing
to genetic variation, these bacteria start producing ﬂagellin
and may exacerbate intestinal inﬂammation. Consistent with
this notion, a previous study showed that the immune
environment regulates the production of ﬂagellin by the
commensal microbiota.29 Thus, the CD microbiota may
become more pathogenic when it is exposed to certain
stimuli. In addition to ﬂagellin production, the gene-based
predictive analysis showed that there are differences in
the metabolic proﬁle of IBD hGB and HC hGB mouse
microbiotas. An increased level of gene expression related to
bacterial metabolic functions, likely crucial for survival and
colonization under normal conditions, was observed in HC
hGB. In UC hGB mice, expression of propanoate metabolism
genes was decreased signiﬁcantly compared with HC hGB
mice, suggesting that the UC microbiota has a defect in the
generation of SCFAs. Consistent with the gene-based pre-
dictive analysis, the actual amount of luminal SCFAs tended
to be lower in UC hGB mice compared with HC hGB mice. In
contrast, succinate levels tended to be higher in UC hGB
mice. Because certain bacteria can generate SCFAs from
succinate,36 this pathway appears to be compromised in the
UC microbiota. Indeed, expression of genes related to suc-
cinate metabolism (propanoate metabolism genes) was
signiﬁcantly lower in UC hGB mice. In CD hGB, the gene-
based predictive analysis showed that the expression of
butanoate (butyrate) metabolism pathway genes was
signiﬁcantly lower than HC hGB mice. However, one
surprising result shown by the metabolome analysis was
that the luminal levels of SCFAs (propionate and butyrate)
tended to be higher in CD hGB mice compared with HC hGB
mice. Given that this evidence of microbiota dysfunction is
consistent with the previous larger cohort study that
analyzed the function of IBD microbiota directly in pa-
tients,12,34 it is conceivable that dysbiosis, reproduced in
hGB mice, resembled, at least to some extent, the functional
abnormalities found in the microbiota of IBD patients.
Moreover, it is noteworthy that the bacterial functions
associated with CD and UC seem to be distinct because both
types of IBD showed similar levels of reduction in bacterial
diversity and richness. These results suggest that the func-
tional impact of the dysbiotic microbiota on host immunity
might be different in CD compared with UC.
Gut dysbiosis and altered host gene expression may
precede inﬂammation as reported in histologically normal
ileal tissues from newly diagnosed patients with CD
colitis.11,13 This evidence supports a primary role for IBD-
associated dysbiosis, but cannot rule out a primary effect
of altered host gene expression driving subclinical inﬂam-
mation and secondary dysbiosis. In the present study, we
have shown that hGB mice colonized with the CD microbiotashowed a stronger expression of epithelial host–defense
responses (eg, Reg3b/g and Saa3) compared with hGB mice
colonized with the HC microbiota. These genes are known to
be induced in response to the attachment of bacteria to the
intestinal epithelium, implying that the CD microbiota con-
tains potential pathobionts residing near the intestinal
epithelium.37 Therefore, dysbiosis may promote altered
gene expression owing to altered host-microbe interactions.
Consistent with this ﬁnding, previous studies have reported
that potentially pathogenic, intestinal epithelium-adhering
bacteria accumulate in CD patients.8,38 In addition to
epithelial responses, our data showed alterations in down-
stream gene expression associated with gut leukocytes. A
variety of genes associated with myeloid and lymphoid cells
and their activation were increased after reconstitution with
IBD compared with HC microbiota. Of note, genes related to
proinﬂammatory features of mononuclear phagocytes, such
as IL1b, Nox2, and inducible nitric oxide synthase were
induced in response to colonization by the pathogenic
microbiota in CD. Furthermore, the gene expression proﬁle
in CD hGB mice showed activation of both innate (NK, ILCs)
and adaptive (Th1, Th17) lymphocytes. Because accumu-
lating evidence indicates that microbiota-induced IL1b is a
key cytokine that promotes differentiation and activation of
Th17 cells as well as group 3 ILCs,39 pathogenic microbiota
in CD patients may elicit these lymphocyte responses
through activation of a mucosal IL1b signaling pathway
(Il1b, il1r2). Interferon (IFN)-g is a cytokine that is believed
to be involved in the pathogenesis of CD,13 and although it
was not detected by the gene expression analysis per se,
genes induced by IFN-g (Iﬁ205, Ciita, Ido, Nos2) were over-
represented in CD hGB. Thus, IFN-g signaling also might be
activated by the dysbiotic microbiota in CD patients.
Expression of other genes, such as those related to solute
carrier families and cytochrome P450 families, were
decreased in CD hGB compared with HC hGB. It is note-
worthy that these immunologic features, both up-regulation
and down-regulation of genes, observed in CD hGB mice
resemble core gene expression patterns in intestinal mucosa
of newly diagnosed, treatment-naive patients with CD.13
Thus, our data support the possibility that immunologic
alterations in CD patients are driven by abnormal gut
microbiota.
As was the case with the luminal metabolites, we noted
differences in the host gene expression proﬁles in UC vs CD
hGB mice. Although host genes induced by colonization of
UC microbiota showed some overlap with those induced by
CD microbiota, genes related to mononuclear phagocyte
development and activation, functions of NK cells, Th1, and
ILC3s were not up-regulated in UC hGB. In contrast, in UC
hGB mice, expression of genes related to Th17 immunity
was greater than that observed in CD hGB mice, although
the microbiota from both types of diseases provoked Th17
responses. Thus, our results have shown that the dysbiotic
microbiota associated with CD and UC differently affect host
immunity.
As further evidence of the negative impact of the dys-
biotic microbiota on host immune regulation, we assessed
the colitogenic capacity of the dysbiotic microbiota. Notably,
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of inﬂammation in WT GF recipient mice, despite the
increase of core proinﬂammatory gene expression
(Figure 6). This indicates that IBD-associated dysbiosis is
not sufﬁcient enough to trigger colitis in most cases. On the
other hand, CD-associated microbiota, but not HC-associated
microbiota, was capable of inducing colitis in IBD-prone
mice. This suggests that additional factors (ie, genetic sus-
ceptibility) might be required to potentiate the colitogenic
capacity of IBD-associated dysbiotic microbiota. The ability
to transfer colitogenic microbiota has been shown previ-
ously using mouse models,40 but the present study is an
important demonstration that the IBD patient-derived
microbiota possesses colitogenic capacity. Thus, the dys-
biotic microbiota in CD patients seems to be pathogenic, and
may contribute to the manifestation of intestinal inﬂam-
mation. Furthermore, IBD hGB mice may serve as an effec-
tive tool to investigate the mechanisms by which the
dysbiotic microbiota promotes aberrant host responses.
It is noteworthy that the microbiota isolated from
patients with UC failed to induce the development of co-
litis even in GF IL10-/- mice (Supplementary Figure 3).
Consistently, there were no obvious changes in proin-
ﬂammatory gene expression in UC hGB mice compared
with CD hGB mice (Figure 5). However, in this study, we
only tested the colitogenic capacity of the microbiota
isolated from 3 UC patients. Therefore, it is possible that
the dysbiotic microbiota in certain populations of UC pa-
tients is capable of inducing the development of colitis-
like, CD-associated microbiota. Moreover, although the
majority of IBD-associated dysbiotic microbiota is not
immediately pathogenic under experimental conditions (3
weeks after colonization), it is possible that longer expo-
sure to the pathogenic microbiota can lead to the devel-
opment of intestinal inﬂammation even in WT recipients.
Further investigation is needed to better characterize
the colitogenic capacity of IBD-associated dysbiotic
microbiota.
Although the humanized GB mouse system is consid-
ered to be the gold standard method for evaluation of
function of the human microbiota in vivo, there are po-
tential pitfalls to consider. The concept of species-speciﬁc
microbiota has been illuminated in experiments showing
that maturation of the gut-associated immune system is
abrogated in GF mice colonized with human- or rat-derived
microbiota as compared with mouse-derived microbiota.41
Furthermore, hGB mice in the aforementioned study were
unable to combat infectious pathogens effectively. In
contrast, other reports have shown that human microbiota
sufﬁciently promotes murine immune responses related to
the induction of colitis.37,38,42 One explanation for this
discrepancy lies in the sites used for analysis. The former
study characterized host immune responses after coloni-
zation with a human microbiota in the small intestine. In
the latter studies, the colon of hGB mice was used to assess
host immune responses. Consistent with this notion, it has
been reported that immune regulation by the resident
microbiota in the small and large intestine is different.43,44
Our results have conﬁrmed that colonization with a humanmicrobiota induces host immune responses in the colonic
mucosa of hGB mice. It is noteworthy that host immune
activation by the species-mismatched microbiota seems to
be reduced compared with colonization by species-speciﬁc
microbiota, although CD microbiota was able to induce
colitis development in IL10-deﬁcient mice. Thus, although
human microbiota can elicit immune development at least
in the colon of gnotobiotic mice, the immune responses
induced by the species-mismatched microbiota may be
weaker than those induced by the species-matched
microbiota.
In this study, we have shown that the hGB mouse system
is a useful model that can be used to investigate the func-
tional role of IBD-associated dysbiotic microbiota. Dysbiosis
alters downstream host immune responses that could serve
a contributory role in disease persistence and ﬂares. Taken
together, these data suggest that dysbiosis in IBD patients is
not merely a secondary change of intestinal inﬂammation.
Although it still remains unclear what drives dysbiosis in
IBD, gut dysbiosis is a key player in the vicious cycle of
intestinal inﬂammation in IBD.References
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